Hisense has started teasing a new E-Ink smartphone, signalling its return to a niche category that has seen little activity in recent years. The company recently shared promotional material for the ...
Value stocks are generally companies that trade at a price below their fundamental value or what their performance suggests they should be worth. Typically, these are shares of companies with solid ...
JackRabbit has made a name for itself by doing things differently in the e-bike world, and now the company is taking that same unconventional approach into cargo territory. This week, the San ...
With a radically innovative AI-native architecture that eliminates the constraints of legacy marketing clouds or fragmented SaaS stacks, Treasure AI helps top brands get their customer experience ...
In this article, we will take a look at the 10 Stocks That Could 10X Over the Next 10 Years. The last few years have been incredible for stock investors, with the S&P 500 returning 86% between 2023 ...
CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the stocks that could 10x over the next 10 years. Piper Sandler boosted its price target for CRISPR Therapeutics AG (NASDAQ:CRSP) to $110 from $105 on ...
Boox has refreshed its ultra-thin Go 10.3 E Ink tablet with a lighter design, the option of a front light or not, and Android 15 for a more productive and versatile device. E Ink tablets have carved ...
There are many E Ink tablets out there, but most of them are basically digital notebooks. They are great for reading and handwriting notes, but not so great for doing all of that regular tablet stuff ...
Add Yahoo as a preferred source to see more of our stories on Google. Close up on a dark bowl full of seasoned you sit ramen noodles with a fork and a spoon - Maliflower73/Getty Images Instant ramen ...
Quince has received $500 million in a late-stage investment round, bringing the consumer technology platform's valuation to $10.1 billion. Quince Series E financing will support the company's ...
Quince has a fresh infusion of cash. The factory-direct luxury essentials player — which has offerings across apparel, accessories, home and beauty — closed on a $500 million series E funding round, ...
The average one-year price target for 10x Genomics (NasdaqGS:TXG) has been revised to $20.33 / share. This is an increase of 10.28% from the prior estimate of $18.43 dated February 1, 2026. The price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results